Last reviewed 2026-04-20 · How we verify

Ambuphylline (bufylline)

unknown active

Ambuphylline (generic name: bufylline) is a bufylline drug. It is currently in unknown development.

Ambuphylline works by blocking the adenosine receptor A1, which helps to increase heart rate and blood pressure.

Ambuphylline, also known as bufylline, is a small molecule drug that targets the adenosine receptor A1. It is a bufylline, a class of drugs that work by modulating adenosine receptors. However, its commercial status and approved indications are unknown. As a result, its half-life, bioavailability, and generic manufacturers are also unclear. Further research is needed to determine its safety and efficacy.

At a glance

Generic name	bufylline
Drug class	bufylline
Target	Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1
Therapeutic area	Cardiovascular
Phase	unknown

Mechanism of action

Think of adenosine like a brake pedal in your car. When adenosine binds to its receptor, it slows down the heart rate and lowers blood pressure. Ambuphylline blocks this brake pedal, allowing the heart to beat faster and blood pressure to rise.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ambuphylline CI brief — competitive landscape report
Ambuphylline updates RSS · CI watch RSS
portfolio CI

Frequently asked questions about Ambuphylline

What is Ambuphylline?

Ambuphylline (bufylline) is a bufylline drug.

How does Ambuphylline work?

Ambuphylline works by blocking the adenosine receptor A1, which helps to increase heart rate and blood pressure.

What is the generic name of Ambuphylline?

bufylline is the generic (nonproprietary) name of Ambuphylline.

What drug class is Ambuphylline in?

Ambuphylline belongs to the bufylline class. See all bufylline drugs at /class/bufylline.

What development phase is Ambuphylline in?

Ambuphylline is in unknown.

What does Ambuphylline target?

Ambuphylline targets Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1 and is a bufylline.

Drug class: All bufylline drugs
Target: All drugs targeting Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1
Manufacturer: — full pipeline
Therapeutic area: All drugs in Cardiovascular

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing